Breast Cancer

References

Citations

1. Beral V; Million Women Study Collaborators (2003). Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet, 362(9382): 419–427.

2. National Cancer Institute (2006). Probability of breast cancer in American women. National Cancer Institute Fact Sheet. Available online: http://www.cancer.gov/cancertopics/factsheet/Detection/probability-breast-cancer.

3. Tamimi RM, et al (2006). Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women. Archives of Internal Medicine, 166(14): 1483–1489.

4. American Cancer Society (2007). Breast Cancer Facts and Figures 2007. Atlanta: American Cancer Society. Available online: http://www.cancer.org/docroot/STT/stt_0.asp.

5. Dallal CM, et al. (2007). Long-term recreational physical activity and risk of invasive and in situ breast cancer. Archives of Internal Medicine, 167(4): 408–415.

6. Paley PJ (2001). Screening for the major malignancies affecting women: Current guidelines. American Journal of Obstetrics and Gynecology, 184(5): 1021–1030.

7. Gradishar WJ (2004). Male breast cancer. In JR Harris et al., eds., Diseases of the Breast, 3rd ed., pp. 983–990. Philadelphia: Lippincott Williams and Wilkins.

8. Canadian Cancer Society (2007). Breast cancer stats. Available online: http://www.cancer.ca/ccs/internet/standard/0,3182,3172_14435_371399_langId-en,00.html.

9. Women's Health Initiative Steering Committee (2004). Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA, 291(14): 1701–1712.

10. Armstrong K, et al. (2000). Assessing the risk of breast cancer. New England Journal of Medicine, 342(8): 564–570.

11. Willett WC et al. (2004). Nongenetic factors in the causation of breast cancer. In JR Harris et al., eds., Diseases of the Breast, 3rd ed., pp. 223–276. Philadelphia: Lippincott Williams and Wilkins.

12. Rosolowich V (2006). Breast self-examination. SOGC Committee Opinion No. 181. Journal of Obstetrics and Gynaecology Canada, 26(8): 728–730.

13. Thomas DB, et al. (2002). Randomized trial of breast self-examination in Shanghai: Final results. Journal of the National Cancer Institute, 94(19): 1445–1457.

14. Mahon SM (2003). Evidence-based practice: Recommendations for the early detection of breast cancer. Clinical Journal of Oncology Nursing, 7(6): 693–696.

15. Saslow D, et al. (2007). American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA: A Cancer Journal for Clinicians, 57(2): 75–89. Available online: http://www.caonline.amcancersoc.org/cgi/content/full/57/2/75.

16. Lehman CD, et al. (2007). MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. New England Journal of Medicine, 356(13): 1295–1303.

17. Veronesi U, et al. (2003). A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. New England Journal of Medicine, 349(6): 546–553.

18. Mansel RE, et al. (2006). Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC trial. Journal of the National Cancer Institute, 98(9): 599–609.

19. Smith RA, D'Orsi CJ (2004). Screening for breast cancer. In JR Harris et al., eds., Diseases of the Breast, 3rd ed., pp. 103–130. Philadelphia: Lippincott Williams and Wilkins.

20. Martelli G, et al. (2005). A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: Results after 5 years of follow-up. Annals of Surgery, 242(1): 1–6.

21. Burstein HJ (2003). Breast cancer: Supportive measures and follow-up care. In B Furie et al., eds., Clinical Hematology and Oncology, pp. 763–768. Philadelphia: Churchill Livingstone.

22. Goss PE, et al. (2003). A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. New England Journal of Medicine, 349(19): 1793–1802.

23. Coombes RC, et al. (2004). A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. New England Journal of Medicine, 350(11): 1081–1092.

24. ATAC Trialists' Group (2005). Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet, 365(9453): 60–62.

25. Thurlimann B, et al. (2005). A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. New England Journal of Medicine, 353(26): 2747–2757.

26. Boccardo F, et al. (2007). Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma. Cancer, 109(6): 1060–1067.

27. Chlebowski T, et al. (2003). Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: The Women's Health Initiative randomized trial. JAMA, 289(24): 3243–3253.

28. Beral V, et al. (2002). Breast cancer and breastfeeding: Collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50,302 women with breast cancer and 96,973 women without disease. Lancet, 360(9328): 187–2218.

29. Prentice RL, et al. (2006). Low-fat dietary pattern and risk of invasive breast cancer. JAMA, 295(6): 629–642.

30. Taylor EF, et al. (2007). Meat consumption and risk of breast cancer in the U.K. women's cohort study. British Journal of Cancer, 96(7): 1139–1146.

31. Cho E, et al. (2006). Red meat intake and risk of breast cancer among premenopausal women. Archives of Internal Medicine, 166(20): 2253–2259.

32. McTiernan A, et al. (2004). Recreational physical activity and the risk of breast cancer in postmenopausal women. JAMA, 290(10): 1331–1336.

33. Vogel VG, et al. (2006). Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NASBP study of tamoxifen and raloxifene (STAR) P-2 trial. JAMA, 295(23): 2727–2741.

34. Abramowicz M (2006). Raloxifene (Evista) for breast cancer prevention in postmenopausal women. Medical Letter on Drugs and Therapeutics, 48(1234): 37.

35. Morrow M, Gradishar W (2002). Breast cancer. BMJ, 324(7334): 410–414.

36. Isaacs C, et al. (2004). Evaluation and management of women with a strong family history. In JR Harris et al., eds., Diseases of the Breast, 3rd ed., pp. 315–345. Philadelphia: Lippincott Williams and Wilkins.

37. McMeely ML, et al. (2006). Effects of exercise on breast cancer patients and survivors: A systematic review and meta-analysis. Canadian Medical Association Journal, 175(1): 34–41.

38. Holmes MD, et al. (2005). Physical activity and survival after breast cancer diagnosis. JAMA, 293(20): 2479–2486.

39. Drouin JS, et al. (2006). Random control clinical trial on the effects of aerobic exercise training on erythocyte levels during radiation treatment for breast cancer. Cancer, 107(10): 2490–2495.

40. Ohira T, et al. (2006). Effect of weight training on quality of life in recent breast cancer survivors: The Weight Training for Breast Cancer Survivors (WTBS) study. Cancer, 106(9): 2076–2083.

41. Collado-Hidalgo A, et al. (2006). Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clinical Cancer Research, 12(9): 2759–2766.

42. Kris MG, et al. (2006). American Society of Clinical Oncology guideline for antiemetics in oncology: Update 2006. Journal of Clinical Oncology, 24(18): 2932–2937.

43. National Cancer Institute (2006). Breast Cancer PDQ: Treatment—Health Professional Version. Available online: http://www.cancer.gov/cancertopics/pdq/treatment/breast/healthprofessional.

44. Harris EER, et al. (2006). Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. Journal of Clinical Oncology, 24(25): 4100–4106.

45. Hooning MJ, et al. (2007). Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. Journal of the National Cancer Institute, 99(5): 365–375.

Other Works Consulted

• Marrett L, et al. (2007). Canadian Cancer Statistics 2007. Toronto: Canadian Cancer Society and National Cancer Institute of Canada. Available online: http://www.bc.cancer.ca/vgn/images/portal/cit_86751114/36/15/1816216925cw_2007stats_en.pdf.

Go to previous section	Go to top of page	Go to next section
Author:	Kathe Gallagher, MSW Ralph Poore	Last Updated: October 22, 2007
Medical Review:	Joy Melnikow, MD, MPH - Family Medicine Anne C. Poinier, MD - Internal Medicine Douglas A. Stewart, MD - Medical Oncology
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.